Hims & Hers Health (HIMS) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
186.8mn → 258.2mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
▲360% YoY in FY25, largest jump in this window; watch free-cash-flow conversion.
$90.0M returned vs $57.4M of FCF in FY25. The gap comes off the balance sheet (see net cash).
5¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Over this window: gross 75.2% → 73.8%. Net margin 5.5% is above the sector median.
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 2,869,509.0 | 2,347,637.0 | 1,476,514.0 | 872,000.0 | 526,916.0 | 271,878.0 | ▲59.0% | +71.4% |
Cost of revenue | 1,038,285.0 | 614,259.0 | 303,379.0 | 157,051.0 | 118,194.0 | 67,384.0 | ▲102.5% | +73.8% |
Gross profit | 1,831,224.0 | 1,733,378.0 | 1,173,135.0 | 714,949.0 | 408,722.0 | 204,494.0 | ▲47.8% | +70.6% |
Research & development | 212,186.0 | 149,301.0 | 78,819.0 | 48,227.0 | 29,237.0 | 22,379.0 | ▲89.4% | +60.7% |
Selling, general & admin | 502,692.0 | 272,724.0 | 167,767.0 | 129,883.0 | 98,192.0 | 113,662.0 | ▲62.6% | +24.5% |
Total operating expenses | 2,063,699.0 | 1,627,765.0 | 1,111,232.0 | 744,402.0 | 477,419.0 | 319,536.0 | ▲46.5% | +50.2% |
Operating incomefeeds ROC rank | −232,475.0 | 105,613.0 | 61,903.0 | −29,453.0 | −68,697.0 | −115,042.0 | ▲70.6% | — |
Other income, net | 10,394.0 | 18,311.0 | 9,808.0 | 7,882.0 | 2,988.0 | 4,247.0 | — | — |
Pretax income | −222,081.0 | 123,924.0 | 71,711.0 | −21,571.0 | −65,709.0 | −110,795.0 | ▲72.8% | — |
Income tax | −31,237.0 | −4,441.0 | −54,327.0 | 1,975.0 | −31.0 | −3,136.0 | ▲91.8% | — |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | −190,844.0 | 128,365.0 | 126,038.0 | −23,546.0 | −65,678.0 | −107,659.0 | ▲1.8% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −0.83 | 0.51 | 0.53 | −0.11 | −0.32 | −0.58 | ▼3.8% | — |
Diluted shares (mn) | 233.82 | 258.23 | 236.81 | 209.34 | 204.52 | 186.78 | ▲9.0% | +8.4% |
| Margins | ||||||||
Gross margin45th pct in Healthcare | 63.8% | 73.8% | 79.5% | 82.0% | 77.6% | 75.2% | ▼5.6pp | −1.4pp |
Operating margin | −8.1% | 4.5% | 4.2% | −3.4% | −13.0% | −42.3% | ▲0.3pp | +46.8pp |
Net margin29th pct in Healthcare | −6.7% | 5.5% | 8.5% | −2.7% | −12.5% | −39.6% | ▼3.1pp | +45.1pp |
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Hims & Hers Health's revenue last fiscal year?
Hims & Hers Health reported revenue of $2,347.6M in fiscal 2025, up 59.0% from fiscal 2024.
What was Hims & Hers Health's net income?
Hims & Hers Health reported net income of $128.4M in fiscal 2025, a net margin of 5.5%.

